CZEREPAK ELIZABETH 4
4 · DELCATH SYSTEMS, INC. · Filed May 14, 2026
Research Summary
AI-generated summary of this filing
Delcath (DCTH) Director Elizabeth Czerepak Receives 22,500-Share Award
What Happened
Elizabeth Czerepak, a director of Delcath Systems, Inc. (DCTH), was granted a derivative award on 2026-05-13 for 22,500 shares. The filing shows an acquisition price of $0.00 for the derivative, indicating an option/award rather than an open-market purchase or sale. No immediate sale or cash proceeds were reported.
Key Details
- Transaction date: 2026-05-13 (reported on Form 4 filed 2026-05-14) — filing appears timely.
- Transaction type/code: A (award/grant); recorded as a derivative security (option/award) at $0.00.
- Shares involved: 22,500 underlying shares granted.
- Vesting/expiration (footnote): Vests at 1/12th per month beginning May 13, 2026 while Czerepak remains a director. Option expires the earlier of 10 years from grant or, for vested options, two years after last day of service.
- Shares owned after transaction: Not specified in the provided filing.
- No indication of a cashless exercise, sale, 10b5-1 plan, tax withholding, or gift in this filing.
Context: This was an equity grant (derivative award) to a director that vests over time; it is not an immediate purchase or sale and therefore does not reflect an immediate market commitment (e.g., neither a direct bullish buy nor a divestiture).
Insider Transaction Report
Form 4
CZEREPAK ELIZABETH
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2026-05-13+22,500→ 22,500 totalExercise: $11.61→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 13, 2026 and monthly thereafter for so long as the reporting person remains a director of the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service.
Signature
/s/ Gerard Michel, Attorney-in-Fact|2026-05-14